Hematopoietic Stem Cell Mobilization for Gene Therapy of Adult Patients With Severe β-Thalassemia: Results of Clinical Trials Using G-CSF or Plerixafor in Splenectomized and Nonsplenectomized Subjects
Molecular Therapy2011Vol. 20(1), pp. 230–238
Citations Over TimeTop 10% of 2011 papers
Evangelia Yannaki, Thalia Papayannopoulou, Erica C. Jonlin, Fani Zervou, Garyfalia Karponi, Angeliki Xagorari, Pamela S. Becker, Nikoletta Psatha, Ioannis Batsis, Panayotis Kaloyannidis, Varvara Tahynopoulou, Varnavas Constantinou, Asimina Bouinta, Konstantia Kotta, Aglaia Athanassiadou, Αchilles Anagnostopoulos, Αthanasios Fassas, George Stamatoyannopoulos
Related Papers
- → Mobilization of hematopoietic stem cells: state of the art(2008)68 cited
- → Lenalidomide-induced upregulation of CXCR4 in CD34+ hematopoietic cells, a potential mechanism of decreased hematopoietic progenitor mobilization(2012)22 cited
- → Can every patient be mobilized?(2010)8 cited
- Rapid Mobilization Reveals a Highly Engraftable Hematopoietic Stem Cell(2018)
- → Successful hematopoietic stem cell collection in patients who fail initial plerixafor mobilization for autologous stem cell transplant(2014)4 cited